Mark Hopman
Chief Commercial Officer · Beta Bionics, Inc.
IndividualSelling only9 10b5-1 trades
- 2025
- Oct 5, 2026
- 16
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Hopman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Saint - $786K in BBNX purchases and sales in the last 12 months
- Stephen Feider - $612K in BBNX purchases and sales in the last 12 months
- Mike Mensinger - $308K in BBNX purchases and sales in the last 12 months
- Christy Jones - $228K in BBNX purchases and sales in the last 12 months
- Steven Jon Russell - $177K in BBNX purchases and sales in the last 12 months
- Adam Lezack - $100K in BBNX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Hopman?
Mark Hopman is a corporate insider, tracked as Chief Commercial Officer of Beta Bionics, Inc. (BBNX). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Hopman submitted recently?
6 primary Form 4 filings in the last 90 days, covering 1 company.
Has Mark Hopman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($2.93M) across all tracked filings.
